Live feed08:30:00·330dPRReleasevia QuantisnowOncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-EndByQuantisnow·Wall Street's wire, on your screen.ONCY· Oncolytics Biotech Inc.Health Care
